OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma
Abstract Functional cellular heterogeneity in tumours often underlies incomplete response to therapy and relapse. Previously, we demonstrated that the growth of the paediatric brain malignancy, sonic hedgehog subgroup medulloblastoma, is rooted in a dysregulated developmental hierarchy, the apex of...
Saved in:
Main Authors: | Kinjal Desai, Siyi Wanggou, Erika Luis, Heather Whetstone, Chunying Yu, Robert J. Vanner, Hayden J. Selvadurai, Lilian Lee, Jinchu Vijay, Julia E. Jaramillo, Jerry Fan, Paul Guilhamon, Michelle Kushida, Xuejun Li, Gregory Stein, Santosh Kesari, Benjamin D. Simons, Xi Huang, Peter B. Dirks |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-54858-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179
by: Yuchen Li, et al.
Published: (2025-02-01) -
Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer
by: Ge Cong, et al.
Published: (2025-02-01) -
Fate of the banished /
by: Ocwinyo, Julius, 1960-
Published: (2008) -
Perivascular space imaging during therapy for medulloblastoma.
by: Ruitian Song, et al.
Published: (2025-01-01) -
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
by: Marta Buzzetti, et al.
Published: (2021-03-01)